Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl

Go back to Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl
(NASDAQ: ADIL) Delayed: 2.59 -0.12 (4.43%)
Previous Close $2.71    52 Week High
Open $2.62    52 Week Low
Day High $2.72    P/E N/A 
Day Low $2.57    EPS
Volume 25,026       

(NASDAQ: ADILW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High
Open $21.03    52 Week Low
Day High $0.00    P/E N/A 
Day Low $0.00    EPS
Volume 182,526